Chip maker RF Micro Devices Inc. and TriQuint Semiconductor Inc. are combining in an all-stock deal valued at about $1.56 billion. The deal announced Monday represents an implied price of $9.73 for each TriQuint share. This is a 5 percent premium to the company's Friday closing price of $9.23.
Eli Lilly is buying a privately held, poultry vaccine maker to strengthen its Elanco animal health subsidiary. No terms were released, but Lilly said Monday that its 2014 earnings forecast will be trimmed due to acquisition costs.
Minority shareholders of Swedish truck maker Scania say they are hesitant about Volkswagen's 6.7 billion-euro ($9.2 billion) offer to take over the rest of the company. Swedish pension fund AP4 said in a statement Monday it will review the offer but that "it is not obvious that the price now offered is best in the long term."
Jack Link’s® announced plans on Friday to purchase Unilever’s® meat snacks business, primarily sold under the BiFi brand (Germany, Benelux, Austria and Switzerland) and the Peperami brand (UK and Ireland). Terms were not disclosed.
Lydall, Inc. (NYSE:LDL), today announced that it has acquired the industrial filtration businesses of Andrew Industries Limited, an Altham, United Kingdom-based corporation, for $83 million in cash. The acquired business consists of operations in the United States, the United Kingdom, and China, and approximately 500 employees.
Toshiba Corp. said Thursday it will spend hundreds of billions of yen by the business year ending March 2018 on mergers and acquisitions to expand its health care business, as part of efforts to make the area a new pillar of its management.
With $158.8 billion in cash on its balance sheet, Apple certainly has the money to buy Tesla, which has a market cap of about $24 billion. Although a pairing of the two companies is a likely long shot and far off at best, it's kind of fun to think about a car made the company that brought us the iPhone and iPad.
Actavis PLC says it will acquire fellow drugmaker Forest Laboratories Inc. in a cash-and-stock deal worth about $25 billion. The deal would create a combined company spanning both generic and branded drugs, including Forest's Alzheimer's treatment Namenda and the antidepressant Lexapro.
The subtle change surfaced this week in Google's 2013 annual report. Google Inc. didn't quantify the total number of deals that it closed last year in the regulatory filing, marking the first time that the U.S. company has withheld that detail since going public in 2004.
While 2013 as a whole marks the second consecutive annual decline, deal activity in the second half of the year increased with 83 deals worth $35.7 billion versus 69 deals for $24 billion in the first half. The fourth quarter of 2013 recorded 40 transactions worth $50 million or more.
Swiss food and drink giant Nestlé and French cosmetics company L'Oréal have approved a deal to transfer ownership of Swiss dermatology pharmaceuticals company Galderma. The companies say L'Oréal will buy 48.5 million of its own shares, or 8 percent of its share capital, from Nestlé and give Nestlé its 50 percent stake in Galderma, which has been a 50/50 joint venture between them.
Microchip Technology is buying mixed signal semiconductor maker Supertex for approximately $246 million, helping to expand the chipmaker's presence in the medical, lighting and industrial markets. Both companies' boards unanimously approved the acquisition. It needs approval from Supertex shareholders.
A bankruptcy judge had rejected Hybrid's plan to use $75 million it claims it is owed as Fisker's senior secured lender on the bid. He capped Hybrid's credit bid at $25 million, setting up a competitive auction with Chinese auto parts conglomerate Wanxiang Group Corp.
Illinois Tool Works is selling its packaging division to The Carlyle Group for $3.2 billion and plans to use the money to buy back shares. Carlyle says the packaging division has 88 manufacturing sites on six continents. Carlyle said in the announcement on Thursday that it will run the packaging group as a stand-alone company.
French-U.S. telecommunications equipment company Alcatel-Lucent SA says it is in talks to sell its business that deals with corporate clients to China Huaxin for around 268 million euros ($362 million). The business, known as Enterprise, has nearly 3,000 employees. The deal is expected to close in the third quarter.
The Whitmore Manufacturing Company announced today its acquisition of Fluid Defense Systems, LLC, a manufacturer of fully-integrated lubricant storage and handling solutions. Whitmore says that since 2001, Fluid Defense had grown to being recognized in lubricant handling and contamination control for food and beverage and industrial manufacturing.
Anheuser Busch InBev's U.S. arm is buying craft brewer Blue Point Brewing Co. Financial terms were not disclosed. Blue Point makes more than 40 craft beers, including Toasted Lager, Hoptical Illusion, Blueberry Ale and seasonal brands, among others.
Amid the news that Chrysler was being merged with its Italian owners Fiat, and many still-unanswered questions about the future of what used to be one of America’s “Big 3” automakers, the company has doubled-down on its very U.S.-focused — and some say ironically xenophobic — advertising scheme.
Entegris Inc. has reached a deal to buy fellow semiconductor materials maker ATMI in a deal worth about $1.15 billion. The deal announced Tuesday brings together two key suppliers in the semiconductor industry to create a leader in advanced process materials, contamination control and wafer handling, Entegris said.
Forest Labs said Monday it completed its $2.9 billion purchase of Aptalis, a company that makes treatments for gastrointestinal problems and cystic fibrosis. Forest said the acquisition of Aptalis will give it about $700 million in revenue in its next fiscal year.
Valeant Pharmaceuticals is looking to expand its skin care business by buying PreCision Dermatology for $475 million. Cumberland, R.I.-based PreCision Dermatology makes treatments for skin ailments such as acne and atopic dermatitis, an itchy, chronic skin inflammation.
Marlboro maker Altria Group Inc. says it is buying electronic cigarette company Green Smoke Inc. for about $110 million. The Richmond, Va.-based owner of Philip Morris USA said Monday that the transaction is expected to close in the second quarter.
Drug developer Bristol-Myers Squibb Co. has received a $2.7 billion payment from Anglo-Swedish counterpart AstraZeneca PLC as part of the sale of its global diabetes business, a deal that could eventually be worth more than $4 billion.
Post Holdings Inc. is buying the PowerBar and Musashi brands from Nestle SA, further diversifying its business by expanding into the active nutrition category. The PowerBar and Musashi brands make premium bars, powders and gels. Musashi is a leading sports nutrition brand in Australia.
The Federal Trade Commission said Friday it has approved Thermo Fisher Scientific Inc.'s $13.6 billion acquisition of Life Technologies Corp., as long as the scientific instrument maker sells some assets to a unit of General Electric Co.